| Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients A Pruvost, E Negredo, H Benech, F Theodoro, J Puig, E Grau, E García, ... Antimicrobial agents and chemotherapy 49 (5), 1907-1914, 2005 | 125 | 2005 |
| SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinité, F Tarrés-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 97 | 2021 |
| Rate and predictors of progression in elite and viremic HIV-1 controllers A Leon, I Perez, E Ruiz-Mateos, JM Benito, M Leal, C Lopez-Galindez, ... Aids 30 (8), 1209-1220, 2016 | 81 | 2016 |
| High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial A Alemany, P Millat-Martinez, M Corbacho-Monné, P Malchair, D Ouchi, ... The Lancet Respiratory Medicine 10 (3), 278-288, 2022 | 69 | 2022 |
| Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease C Casado, M Pernas, T Alvaro, V Sandonis, S García, C Rodríguez, ... Journal of Infectious Diseases 196 (6), 895-899, 2007 | 63 | 2007 |
| ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression E Ballana, J Senserrich, E Pauls, R Faner, JM Mercader, F Uyttebroeck, ... Clinical Infectious Diseases 50 (7), 1022-1032, 2010 | 51 | 2010 |
| Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors N González, K McKee, RM Lynch, IS Georgiev, L Jimenez, E Grau, ... PloS one 13 (3), e0193773, 2018 | 42 | 2018 |
| Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller M Pernas, C Casado, C Arcones, A Llano, V Sánchez-Merino, B Mothe, ... PLoS One 7 (2), e31928, 2012 | 31 | 2012 |
| Identification of a cluster of HIV-1 controllers infected with low replicating viruses C Casado, M Pernas, V Sandonis, T Alvaro-Cifuentes, I Olivares, ... PLoS One 8 (10), e77663, 2013 | 27 | 2013 |
| Differential prevalence of the HLA-C− 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals E Ballana, A Ruiz-de Andres, B Mothe, ER de Arellano, F Aguilar, R Badia, ... Immunobiology 217 (9), 889-894, 2012 | 25 | 2012 |
| Previous SARS-CoV-2 infection increases B. 1.1. 7 cross-neutralization by vaccinated individuals B Trinité, E Pradenas, S Marfil, C Rovirosa, V Urrea, F Tarrés-Freixas, ... Viruses 13 (6), 1135, 2021 | 22 | 2021 |
| Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individuals E Ballana, E Gonzalo, E Grau, JA Iribarren, B Clotet, JA Este AIDS 26 (4), 527-528, 2012 | 14 | 2012 |
| Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities M Trigueros, E Pradenas, D Palacín, F Muñoz-López, C Ávila-Nieto, ... Age and ageing 51 (5), afac101, 2022 | 11 | 2022 |
| Prevalence of HIV-1 Dual Infection in Long-Term Nonprogressor–Elite Controllers M Pernas, C Casado, V Sandonis, C Arcones, C Rodríguez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (3), 225-231, 2013 | 9 | 2013 |
| Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: a cross sectional study E Abella, E Pradenas, F Muñoz-Lopez, F Garcia-Pallarols, RBAB Lahsen, ... Life Science Alliance 5 (12), 2022 | 5 | 2022 |
| Small form factor flow virometer for SARS-CoV-2 R Hussain, AE Ongaro, MLR de la Concepción, E Wajs, E Riveira-Muñoz, ... Biomedical Optics Express 13 (3), 1609-1619, 2022 | 5 | 2022 |
| Vagus nerve dysfunction in the post–COVID-19 condition: a pilot cross-sectional study G Lladós, M Massanella, R Coll-Fernández, R Rodríguez, E Hernández, ... Clinical Microbiology and Infection 30 (4), 515-521, 2024 | 4 | 2024 |
| Vagus nerve dysfunction in the post-COVID-19 condition G Lladós, M Massanella, R Coll-Fernández, R Rodríguez, E Hernández, ... | 4 | 2023 |
| Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization E Pradenas, S Marfil, V Urrea, T Pidkova, A Pons-Grífols, R Ortiz, ... Iscience 26 (4), 2023 | 3 | 2023 |
| Limited immune responses after three months of BNT162b2 vaccine in SARS-CoV-2 uninfected elders living in long-term care facilities M Trigueros, E Pradenas, D Palacín, C Ávila-Nieto, B Trinité, ... medRxiv, 2021.11. 18.21266502, 2021 | 2 | 2021 |
